Rokit Healthcare Inc. logo

Rokit Healthcare Inc. (376900)

Market Open
12 Aug, 05:41
KRX SM KRX SM
34,450. 00
-500
-1.4306%
- Market Cap
- P/E Ratio
- Div Yield
97,364 Volume
- Eps
34,950
Previous Close
Add Transaction
Day Range
33,700 35,150
Year Range
14,120 153,800
Want to track 376900 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

376900 trading today lower at ₩34,450, a decrease of -1.4306% from yesterday's close, completing a monthly increase of 11.6694% or ₩3,600. Over the past 12 months, 376900 stock lost -47.803%.
376900 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

376900 Chart

Rokit Healthcare Inc. (376900) FAQ

What is the stock price today?

The current price is ₩34,450.00.

On which exchange is it traded?

Rokit Healthcare Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 376900.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Rokit Healthcare Inc. ever had a stock split?

No, there has never been a stock split.

Rokit Healthcare Inc. Profile

- Industry
- Sector
Mr. Seok-hwan Yoo CEO
KRX SM Exchange
- ISIN
South Korea Country
74 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Rokit Healthcare Inc. is a pioneering biotechnology company that focuses on hyper-personalized organ regenerative healthcare solutions. Established in 2012 and based in Seoul, South Korea, Rokit Healthcare is renowned for its innovative contributions to medical 3D bioprinting technology. The company specializes in advanced bioprinters and disposable medical device kits that are specifically designed for regenerative therapies. By combining cutting-edge technology with a deep understanding of regenerative medicine, Rokit Healthcare aims to transform treatment paradigms for chronic and degenerative diseases through personalized and autologous therapies.

Products and Services

  • Advanced Bioprinters:

    Rokit Healthcare offers state-of-the-art bioprinters that enable the precise and efficient bioprinting of various tissues and organs. These machines are designed to support research and clinical applications in regenerative medicine, allowing for the production of customized biological structures tailored to individual patient needs.

  • Disposable Medical Device Kits:

    These kits include all necessary tools and materials for conducting regenerative therapy procedures. Each kit is designed to ensure sterile conditions and ease of use, making it accessible for healthcare professionals to implement advanced regenerative techniques in their practices.

  • Skin Regeneration Therapies:

    Rokit Healthcare provides specialized solutions for skin regeneration, particularly aimed at treating diabetic foot ulcers. These therapies leverage innovative materials and technologies to promote healing and tissue restoration, improving the quality of life for patients.

  • Cartilage Regeneration Products:

    The company develops solutions targeting cartilage regeneration for osteoarthritis patients, focusing on restoring the cartilage architecture and function through innovative therapies that promote natural healing processes.

  • Kidney Regeneration Solutions:

    Rokit Healthcare addresses chronic kidney disease through advanced regenerative techniques. Their products are designed to facilitate the regeneration of kidney tissues, aiming to restore kidney function and enhance patient outcomes.

  • Bioinks:

    These biocompatible inks are essential for the 3D bioprinting process, allowing for the creation of complex tissue structures. Rokit Healthcare's bioinks are formulated to support cell viability, differentiation, and integration with existing tissues.

  • Human Adult Stem Cell Culture Media:

    The company offers specialized media for the culture and expansion of human adult stem cells, crucial for regenerative therapies and research applications. These media are optimized to support the growth and maintenance of stem cell populations.

  • Reconstructed Human Epidermis Models:

    Rokit Healthcare develops advanced reconstructed human epidermis models used for drug testing and skin research. These models help researchers better understand skin biology and evaluate the effects of treatments before clinical applications.

  • Anti-Aging Supplements:

    The company explores the intersection of biotechnology and wellness by offering supplements aimed at promoting longevity and reducing the effects of aging. These products are formulated based on research in regenerative medicine and cellular health.

Contact Information

Address: Digital-ro 10-gil 9
Phone: 82 1 899 7296